Cyclo Spray, Chlortetracycline Hci 2.45% W/W, Cutaneous Spray, Suspension For Pigs, Sheep And Cattle
Revised: April 2012
AN: 01788/2011
SUMMARY OF PRODUCT CHARACTERISTICS
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cyclo Spray, Chlortetracycline HCl 2.45 % w/w, cutaneous spray, suspension for pigs, sheep and cattle.
2. Qualitative and quantitative COMPOSITION
Active Substance:
Chlortetracycline HCl.
The active ingredient content is 2.45 % w/w
Excipients:
Patent Blue V, colouring agent 0.15 % w/w
Butane 100 68.77 % w/w
For a full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Cutaneous Spray, suspension
Blue colored
4. CLINICAL PARTICULARS
4.1 Target species
Cattle, sheep and pigs.
4.2 Indications for use, specifying the target species
-
Prevention of infections of superficial traumatic or surgical wounds caused by micro-organisms sensitive to chlortetracycline.
-
The product can be used as part of a treatment for superficial claw/hoof infections, in particular interdigital dermatitis (foot rot) in sheep and digital dermatitis in cattle.
4.3 Contraindications
Do not use in case of hypersensitivity to tetracyclines.
4.4 Special warnings for each target species
None
4.5 Special precautions for use
Special precautions for use in animals
Protect the eyes when spraying in the vicinity of the head. Clean the affected area thoroughly before spraying. Treatment of foot conditions should always be preceded by appropriate paring of the hoof, as this is critical for achieving an adequate response. After spraying the feet, the animal should be kept on dry ground for at least one hour.
The animal should be discouraged from licking the treated area, or treated areas on other animals.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Direct contact with the skin should be avoided because of sensitisation, contact dermatitis and possible hypersensitivity reactions to chlortetracycline.
Wear appropriate impermeable gloves whilst handling the product.
Because of risk of eye irritation, contact with the eyes should be avoided. Protect the eyes and face.
Do not spray on a naked flame or any incandescent material. Do not pierce or burn the container, even after use.
Avoid inhaling vapours. Apply the product in open air or in sufficiently ventilated area.
Wash hands after use.
Do not eat or smoke whilst administering the product.
In case of accidental ingestion or in case of contact with eyes, seek medical advice immediately and show the label to the physician.
4.6 Adverse reactions (frequency and seriousness)
Hypersensitivity reactions may occur rarely.
4.7 Use during pregnancy, lactation or lay
Following cutaneous administration of CYCLO SPRAY, absorption of chlortetracycline is negligible and it is not detectable in the milk.
4.8 Interactions with other veterinary medicinal products and other forms of interaction
After cutaneous administration of chlortetracycline spray, absorption of chlortetracycline is negligible. No data on interactions with other local treatments are available.
4.9 Amounts to be administered and administration route
CYCLO Spray is indicated for cutaneous administration. Shake the container thoroughly before spraying. The container should be held at a distance of 15-20 cm from the area to be sprayed; spray for approximately 3 seconds (equivalent to approximately 3.9 g of product or 0.10 g chlortetracycline) until the treatment-area is evenly coloured. In case of claw/hoof infections this treatment should be repeated after 30 seconds.
For prevention of infections after superficial traumatic or surgical wounds a single administration is recommended.
-
For treatment of Dermatitis Digitalis, a double administration (with a 30 second interval) is recommended daily for three consecutive days.
-
For treatment of other hoof infections (foot rot), a double administration (with a 30 second interval) is recommended. Dependent on the seriousness of the injury and the rate of improvement treatment should be repeated within 1 to 3 days
4.10 Overdose (symptoms, emergency procedures, antidotes) if necessary
Not applicable
4.11 Withdrawal periods
Meat : zero days
Milk : zero hours
Do not use on the udder of lactating animals if milk is intended for human consumption.
Stained part of the pigskin must be removed prior to the rest of the animal being used for human consumption.
5. PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
Chlortetracycline belongs to the pharmacotherapeutic group of tetracycline antibiotics.
ATC vet code:QD06AA02
In vitro, chlortetracycline is primarily bacteriostatic. Chlortetracycline exerts its action by inhibiting the protein synthesis of the bacterial cell. Especially cell-division and the formation of the cell wall are impaired. Chlortetracycline binds to receptors on the 30S-subunit of the bacterial ribosome where they interfere with the binding of the aminoacyl-transfer RNA to the acceptor site on the messenger RNA ribosome complex.
5.2 Pharmacokinetic particulars
Following cutaneous administration of chlortetracycline spray, chlortetracycline absorption is negligible. Therefore CYCLO SPRAY will only have a local effect, no systemic effects are to be anticipated.
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Patent Blue V [E 131]
Butane (Butan 100)
Colloidal anhydrous silica (Aerosil 200)
Isopropyl alcohol
Sorbitan trioleate (Span 85)
6.2 Incompatibilities
None known
6.3 Shelf life
Shelf-life of the veterinary medicinal product as packaged for sale: 3 years
6.4 Special precautions for storage
Pressurized container. Do not expose the container to direct sunlight or to temperatures higher than 50°. Keep away from sources of ignition.
6.5 Nature and composition of immediate packaging
270 ml or 520 ml pressurised container of coated tin plate with a plastic valve mechanism and spraying nozzle. Not all pack sizes may be marketed.
6.6 Special precautions for the disposal of unused veterinary medicinal products or waste materials
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
7. MARKETING AUTHORISATION HOLDER
Eurovet Animal Health B.V.
Handelsweg 25
PO Box 179
5530 AD Bladel
The Netherlands
8. MARKETING AUTHORISATION NUMBER
Vm16849/4002
9. DATE OF FIRST AUTHORISATION
Date:14 August 2006
10. DATE OF REVISION OF THE TEXT
Date:April 2012
Page 4 of 4